AustralianSuper’s Chemours CC Stock Holding History

AustralianSuper’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-501,584	Closed	-$7.49M	–	165
2019 Q3	$7.49M	Buy	501,584 +262,579	+110%	+$4.27M	0.07%	124
2019 Q2	$5.74M	Buy	239,005 +52,254	+28%	+$1.54M	0.06%	129
2019 Q1	$6.94M	Buy	186,751 +148,907	+393%	+$5.42M	0.07%	121
2018 Q4	$1.07M	Buy	+37,844	New	+$1.2M	0.02%	124

Other funds holding CC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return

Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AustralianSuper's CC Position: Q4 2019 in Review

AustralianSuper sold out of Chemours (CC) in Q4 2019, closing a stake of 501,584 shares — an estimated $7.49M sold.

AustralianSuper first reported a position in CC in Q4 2018 and held it in 4 quarters. The position peaked at $7.49M in Q3 2019. 439 funds tracked by Wall St. Rank hold CC as of Q4 2019.

AustralianSuper reported no remaining Chemours position as of Q4 2019 after selling out during the quarter.
AustralianSuper sold 501,584 Chemours shares in Q4 2019, an estimated $7.49M.
AustralianSuper first reported a position in Chemours in Q4 2018 and held it in 4 quarters.
AustralianSuper's Chemours position peaked at $7.49M in Q3 2019.
439 funds tracked by Wall St. Rank held Chemours as of Q4 2019.

Based on AustralianSuper's 13F filing for Q4 2019, filed 10 Feb 2020.